Analysis of HIV-1 integrase gene polymorphism in an HIV-infected population from the nosocomial outbreak of HIV infection in the south of Russia in 1989


Cite item

Full Text

Abstract

The paper presents the data of an investigation of the polymorphism of the pol gene encoding HIV-1 integrase in a HIV subtype G infected population formed during the 1989 HIV-infection outbreak. The investigators analyzed 41 samples of the viruses obtained in 2005-2007. Polymorphism at codons associated with integrase resistance to chemicals was observed in 11 virus variants. The circulation of mutation viruses that potentially promote the formation of resistance to the integrase inhibitors raltegravir and elvitegravir has been established in untreated patients.

References

  1. Пазилин А. С., Саухат С. Р. и др. Генетическая характеристика обратной транскриптазы субтипа G ВИЧ-1 // Вопр. вирусол. - 2007. - № 1. - С. 17-23.
  2. Покровский В. В., Ерамова И. Ю. и др. Внутрибольничная вспышка ВИЧ-инфекции в Элисте // Журн. микробиол. - 1990. - № 4. - С. 17-23.
  3. Ромашкин П. А., Саухат С. Р., Шемшура А. Б. и др. Ретроспективный анализ популяционной изменчивости области V3 gp120 в когорте ВИЧ-инфицированных, имеющих единый источник заражения // Вопр. вирусол. - 2003. - № 4. - С. 20-26.
  4. Barbaro G. et al. Highly active antiretroviral therapy: current state of the art, new agents and their pharmacilogical interactions useful for improving therapeutic outcome // Curr. Pharm. Des. - 2005. - Vol. 11. - P. 1805-1843.
  5. Chen X., Tsiang M., Yu F. et al. Modeling, analysis, and validation of a novel HIV integrase structure provide insights into the binding modes of potent integrase inhibitors // J. Mol. Biol. - 2008. - Vol. 380. - P. 504-519.
  6. Cohen J. Therapies. Confronting the limits of success // Science. - 2002. - Vol. 296. - P. 2320-2324.
  7. Cohen J. Retrovirus meeting. Novel attacks on HIV move closer to reality // Science. - 2006. - Vol. 311. - P. 943.
  8. Fujishita T., Yoshinaga T., Sato A. Preparation of aromatic heterocycle compounds having HIV integrase inhibiting activities. - Int. Patent WO2000039086 (The World Intellectual Property Organization), 2000.
  9. Hazuda D. J., Miller M. D., Nguyen B. Y. et al. Resistance to the HIV-integrase inhibitor raltegravir: analysis of protocol 005, a phase II study in patients with triple-class resistant HIV-1 infection // Program and Abstracts of the XVI International HIV Drug Resistance Workshop, June 12-16, 2007. - St. Michael, Barbados, 2007. - Abstr. 8.
  10. Malet I., Delelis O., Valantin M. et al. Mutations associated with failure of raltegravir treatment affect integrase senditivity to the inhibitor in vitro // Antimicrob. Agents Chem. - 2008. - Vol. 52. - P. 1351-1358.
  11. Marchand C., Zhang X., Pais G. C. et al. Structural determinants for HIV-1 integrase inhibition by beta-diketo acids // J. Biol. Chem. - 2002. - Vol. 277. - P. 12596-12603.
  12. Markowitz M., Morales-Ramirez J. O., Nguyen B. Y. et al. Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals // J. Acquir. Immune Defic. Syndr. - 2006. - Vol. 43. - P. 509-515.
  13. Miller M., Witmer M., Stillmock K. et al. Biochemical and antiviral activity of MK-0518, a potent HIV integrase inhibitor // Abstracts of XVI International AIDS Conference, 13-18 August 2006. - Toronto, Canada. - 2006. - Abstr. THAA0302.
  14. Pommier Y. et al. Integrase inhibitors to treat HIV/AIDS // Nat. Rev. Drug Discov. - 2005. - Vol. 4. - P. 236-248.
  15. Sato M. et al. Novel HIV-1 integrase inhibitors derived from quinolone antibiotics // J. Med. Chem. - 2006. - Vol. 49. - P. 1506-1508.
  16. Sato M., Kawakami H., Itoh Y. et al. Preparation of 4-oxoquinoline derivatives as HIV integrase inhibitors // J. Med. Chem. 2004. - Vol. 47. - P. 5298-5303.
  17. Shimura K., Kodama E., Sakagami Y. et al. Broad antiretroviral activity and resistance profile of the novel human immunodeficiency virus integrase inhibitor elvitegravir (JTK-303/GS-9137) // J. Virol. - 2008. - Vol. 82. - P. 764-774.
  18. Wai J. S., Egbertson M. S., Payne L. S. et al. 4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells // J. Med. Chem. - 2000. - Vol. 43. - P. 4923- 4926.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

Copyright (c) 2010 Gafarova I.E., Shideyeva Z.A., Sandzhiyeva D.B., Garaev M.M.

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС77-77676 от 29.01.2020.


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies